You just read:

Trelegy Ellipta approved as the first once-daily single inhaler triple therapy for the treatment of appropriate patients with COPD in the US

News provided by

GlaxoSmithKline plc , Innoviva, Inc.

Sep 18, 2017, 20:30 ET